Pro Dex (PDEX) EBIT Growth (3y) (2013 - 2026)
Powered by 
Analysis
Pro Dex (PDEX) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 3.16% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 28.02% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 11.63% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 19.80% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 31.84% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 24.88% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -65.59% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 35.44% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 13.06% |
| 10 | Pro Dex | 192.84 Mn | 183.45 Mn | 7.09 Mn | 29.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.90% |
| Mar 31, 2026 | 14.43% |
| Dec 31, 2025 | 42.05% |
| Sep 30, 2025 | 48.47% |
| Jun 30, 2025 | 4.34% |
| Mar 31, 2025 | 52.77% |
| Dec 31, 2024 | 18.89% |
| Sep 30, 2024 | 31.73% |
| Jun 30, 2024 | 58.54% |
| Mar 31, 2024 | 5.87% |
| Dec 31, 2023 | 14.25% |
| Sep 30, 2023 | 5.77% |
| Sep 30, 2016 | 140.74% |
| Mar 31, 2016 | 27.34% |
| Sep 30, 2015 | -31.78% |
| Mar 31, 2015 | -11.28% |
| Mar 31, 2014 | -33.09% |
| Dec 31, 2013 | -38.53% |
| Sep 30, 2013 | -62.71% |